Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Aqdot Limited currently manages 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 3 distinct examiners and 3 distinct art units. This distribution indicates that the company's patent activities are spread across multiple specialized review groups within the USPTO. Practitioners must navigate the different requirements of 3 distinct art units, making the prosecution strategy for this Biotechnology & Pharmaceuticals portfolio more diverse than a single-examiner portfolio.
The busiest examiner for this portfolio is ROZOF, TIMOTHY R, who is responsible for 1 pending office action. Although identified as the busiest, this examiner handles only a portion of the workload, as the total pending office actions count is 3. The fact that there are 3 distinct examiners for 3 pending actions shows that each matter is being reviewed by a different individual. Success in this technology area depends on addressing the unique procedural preferences of each assigned examiner. Practitioners should monitor the specific history of ROZOF, TIMOTHY R while also preparing for the distinct approaches of the other examiners involved.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROZOF, TIMOTHY R | 1 | 72.7% | +23.6% |
| WELLES, COLMAN THOMAS | 1 | 29.2% | +64.2% |
| DIGGS, TANISHA | 1 | 55.1% | +53.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18013073 | A METHOD OF DISINFECTING A GASEOUS ENVIRONMENT, A LIQUID, OR A SOLID SURFACE | WELLES, COLMAN THOMAS | 26d overdue |
| 17633367 | A METHOD FOR REDUCING MALODOUR USING CUCURBITRILS | DIGGS, TANISHA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18013073 | A METHOD OF DISINFECTING A GASEOUS ENVIRONMENT, A LIQUID, OR A SOLID SURFACE | WELLES, COLMAN THOMAS | 26d overdue |
| 18030336 | A METHOD FOR REDUCING ALLERGENS | ROZOF, TIMOTHY R | 12d |
| 17633367 | A METHOD FOR REDUCING MALODOUR USING CUCURBITRILS | DIGGS, TANISHA | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1612 | 1 |
| 1761 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18030336 | A METHOD FOR REDUCING ALLERGENS | ROZOF, TIMOTHY R | 1625 | §102 | Final Rejection | 12d | Pending | Apr 05, 2023 |
| 18013073 | A METHOD OF DISINFECTING A GASEOUS ENVIRONMENT, A LIQUID, OR A SOLID SURFACE | WELLES, COLMAN THOMAS | 1612 | §103§112DP | Non-Final OA | 26d overdue | Pending | Dec 27, 2022 |
| 17633367 | A METHOD FOR REDUCING MALODOUR USING CUCURBITRILS | DIGGS, TANISHA | 1761 | §103§112 | Non-Final OA | — | Pending | Feb 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial